Sinupret extract
Natural health product licensed in Canada
- Licence holder
- Bionorica SE
- NPN or DIN-HM
- 80070881
- Status
- Active licence
- Licence date
- 6 July 2016
- Revision date
- Not provided
- Form
- Comprimé enrobé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sambucus nigra subsp. nigra Source : Fleur Extraction ratio : 4.5:1 Dry plant equivalent : 167 milligramme | 37 milligramme | Not calculated |
| Gentiane Source : Racine Extraction ratio : 4.5:1 Dry plant equivalent : 54 milligramme | 12 milligramme | Not calculated |
| Primula veris Source : Fleur Extraction ratio : 4.5:1 Dry plant equivalent : 167 milligramme | 37 milligramme | Not calculated |
| Rumex crispus Source : Plante Extraction ratio : 4.5:1 Dry plant equivalent : 167 milligramme | 37 milligramme | Not calculated |
| Verbena officinalis Source : Plante Extraction ratio : 4.5:1 Dry plant equivalent : 167 milligramme | 37 milligramme | Not calculated |
Non-medicinal ingredients
Acide stéarique, Cire de Carnauba, Riboflavine, D-glucose, Acacia, Laque d'aluminium-carmin d'indigo, Sucrose, Dérivé potassium-cuivre de la chlorophylline, Maltodextrine, silice, Hypromellose, Stéarate de magnésium, Talc, cellulose, Dextrine, chlorophylline de cuivre sodium, Carbonate de calcium, Dioxyde de titane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides symptomatic relief of nasal congestion and headaches in those suffering from acute uncomplicated inflammations of the paranasal sinuses (acute uncomplicated rhinosinusitis).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80070881
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.